Wockhardt in downtrend, looks weak: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Wockhardt is in a downtrend and looks fairly weak in the short-term and that applies to most stocks because the Nifty is in a correction. On a much longer timeframe, three-five years all pharmaceutical stocks are good."

"One should spread investments in Dr Reddy's Laboratories, Sun Pharmaceutical Industries, Cipla, Wockhardt and Lupin and even if there is company specific adverse information in one, it becomes kind of a pharma index," he said.

Disclosure: Analyst does not have positions in the stocks.